Dian Diagnostics Group Co.,Ltd. Stock price

Equities

300244

CNE1000015N1

Healthcare Facilities & Services

End-of-day quote Shenzhen S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
17.77 CNY +0.68% Intraday chart for Dian Diagnostics Group Co.,Ltd. -10.43% -25.37%
Sales 2023 * 13.77B 1.91B Sales 2024 * 15.68B 2.17B Capitalization 11.03B 1.53B
Net income 2023 * 627M 86.76M Net income 2024 * 1.06B 147M EV / Sales 2023 * 0.97 x
Net Debt 2023 * 2.27B 314M Net Debt 2024 * 2.63B 364M EV / Sales 2024 * 0.87 x
P/E ratio 2023 *
16.9 x
P/E ratio 2024 *
10.3 x
Employees 13,128
Yield 2023 *
0.52%
Yield 2024 *
0.73%
Free-Float 35.04%
More Fundamentals * Assessed data
Dynamic Chart
Dian Diagnostics Group Co.,Ltd. announces an Equity Buyback for CNY 200 million worth of its shares. CI
Dian Diagnostics Group Co.,Ltd. authorizes a Buyback Plan. CI
Dian Diagnostics Expands to Middle East With UAE Collaboration MT
Dian Diagnostics Group Co.,Ltd. Announces Executive Appointments CI
Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Dian Diagnostics Group Co.,Ltd. Announces Final Cash Dividend for A Shares, Payable on 31 May 2023 CI
Dian Diagnostics Group Co.,Ltd. Approves Cash Dividend for 2022 CI
Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Dian Diagnostics Group Co.,Ltd. Announces the Profit Distribution Proposal for 2022 CI
Dian Diagnostics Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Geneus Tech announced that it has received funding from GF Xinde Investment Management Co., Ltd, Dian Diagnostics Group Co.,Ltd. CI
Tranche Update on Dian Diagnostics Group Co.,Ltd.'s Equity Buyback Plan announced on December 7, 2022. CI
Dian Diagnostics Group Co.,Ltd.'s Equity Buyback announced on December 7, 2022, has expired with 1,918,600 shares, representing 0.31% for CNY 49.99 million. CI
Tranche Update on Dian Diagnostics Group Co.,Ltd.'s Equity Buyback Plan announced on December 7, 2022. CI
More news
1 day-0.84%
1 week-11.04%
Current month-8.07%
1 month-8.36%
3 months-25.46%
6 months-26.15%
Current year-25.87%
More quotes
1 week
17.49
Extreme 17.49
19.03
1 month
17.49
Extreme 17.49
20.60
Current year
15.28
Extreme 15.28
23.88
1 year
15.28
Extreme 15.28
30.65
3 years
15.28
Extreme 15.28
41.68
5 years
15.28
Extreme 15.28
52.38
10 years
14.11
Extreme 14.11
86.97
More quotes
Managers TitleAgeSince
Founder 55 95-12-31
Director of Finance/CFO 56 23-08-28
Director/Board Member 68 19-05-21
Members of the board TitleAgeSince
Director/Board Member 55 17-07-16
Founder 55 95-12-31
Director/Board Member 65 15-01-29
More insiders
Date Price Change Volume
24-03-27 17.77 +0.68% 11 546 400
24-03-27 17.65 -0.84% 10,253,270
24-03-26 17.8 -0.56% 12,207,220
24-03-25 17.9 -3.19% 11,782,280
24-03-22 18.49 -2.07% 19,525,600

End-of-day quote Shenzhen S.E., March 26, 2024

More quotes
Dean Diagnostic Technology Group Co., Ltd. is a company providing integrated solutions for medical diagnosis. The Company's main business involves inspection services, product services, health management, judicial expertise, contract research organization (CRO), cold chain logistics and other fields. The Company's business is mainly oriented to medical and health institutions at all levels, such as various general and specialized hospitals, community health service centers, township (town) health centers, physical examination centers, disease prevention and control centers, etc. The Company's products include Atomic Bomb in the field of liquid phase mass spectrometry, Hydrogen Bomb in the field of nucleic acid mass spectrometry, and Man-Made Satellite in the field of pathological diagnosis products and molecular diagnosis products, and others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
17.65 CNY
Average target price
29.08 CNY
Spread / Average Target
+64.77%
Consensus
  1. Stock
  2. Equities
  3. Stock Dian Diagnostics Group Co.,Ltd. - Shenzhen S.E.